Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
Habip Gedik,1 Funda Şimşek,1 Arzu Kantürk,1 Taner Yildirmak,1 Deniz Arica,2 Demet Aydin,2 Naciye Demirel,2 Osman Yokuş2 1Department of Infectious Diseases and Clinical Microbiology, 2Department of Hematology, Ministry of Health Okmeydani Training and Research Hospital, İstanbul, Turkey Background: T...
Saved in:
Main Authors: | Gedik H (Author), Şimşek F (Author), Kantürk A (Author), Yildirmak T (Author), Arica D (Author), Aydin D (Author), Demirel N (Author), Yokuş O (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
by: Gedik H, et al.
Published: (2014) -
Antibiotic resistance status and its costs in hematological patients: A two-year analysis
by: Habip Gedik
Published: (2017) -
Jak-2 mutation frequency in patients with thrombocytosis
by: Osman Yokus, et al.
Published: (2018) -
Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options
by: Lining Zhang, et al.
Published: (2023) -
Advances in Hematologic Malignancies
Published: (2019)